Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: J Matern Fetal Neonatal Med. 2020 Jan 13;35(1):58–65. doi: 10.1080/14767058.2020.1711728

Table 3.

Linear regression models for the relationship between maternal race and ethnicity and percent of elevated glucoses when pharmacotherapy was initiated

Percent of abnormal blood glucose values prior to pharmacotherapy initiation Adjusted linear regression coefficient (95% CI) p-value
Race
 Non-Hispanic White Ref
 Non-Hispanic Black 18.12 (11.26 – 24.98) <0.001
 Hispanic 13.24 (5.05 – 21.43) 0.002
 Other 9.76 (2.61 – 16.91) 0.008
Maternal age −0.01 (−0.48 – 0.48) 0.998
Body mass index in early pregnancy(kg/m2) 0.43 (0.16 – 0.70) 0.002
Marital Status
 Single Ref
 Married −2.83 (−8.64 – 2.97) 0.338
 Divorced 5.42 (−7.92 – 18.76) 0.425
Insurance Status
 Private Ref
 Public 6.21 (0.18 – 12.24) 0.043
 None −5.22 (−13.16 – 2.72) 0.197
Preexisting hypertension
 No Ref
 Yes −0.65 (−12.13 – 10.83) 0.912
Gestational age at GDM diagnosis (wks) 0.18 (−0.22 – 0.58) 0.380

Bold indicates significant p-value